New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
09:12 EDTDTEGY, MTN, TEVA, BIG, S, PBY, GALE, PCS, ESIO, TOL, DRIOn The Fly: Pre-market Movers
HIGHER AFTER EARNINGS: Big Lots (BIG), up 7.3%... Toll Brothers (TOL), up 4.6%... ALSO HIGHER: Galena Biopharma (GALE), up 15% after signing NeuVax commercialization partnership with Teva (TEVA)... Electro Scientific (ESIO), up 12% after declaring $2/share special dividend... LOWER AFTER EARNINGS: Pep Boys (PBY), down 8.7%... Vail Resorts (MTN), down 7.3%... ALSO LOWER: Darden (DRI), down 8.9% after warning on Q2, FY13 EPS... MetroPCS (PCS), down 6.6% after Reuters says Sprint (S) unlikely to counter T-Mobile's (DTEGY) bid.
News For DRI;BIG;TOL;GALE;TEVA;ESIO;PBY;MTN;PCS;S;DTEGY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
June 23, 2015
16:29 EDTDRIOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
14:16 EDTTEVABMO Capital sees strong fundamentals in Perrigo regardless of Mylan deal
Shares of Perrigo (PRGO) are trading higher intraday after BMO Capital Markets initiated coverage of the stock with an Outperform rating. The research firm is bullish on the shares regardless of whether Mylan's bid for the company succeeds, saying Perrigo is well-positioned to ride momentum in reduced-price healthcare. WHAT'S NEW: BMO Capital Markets' David Maris initiated coverage of Perrigo with an Outperform rating and a $246 price target. Maris cited the company's 70%-plus market share in store- and private-label brands, as well as its roughly $1B annual sales in the generics space. The analyst believes Perrigo will see continued benefit from larger trends driving consumer-centric healthcare and the curtailing of medical costs. WHAT'S NOTABLE: BMO Capital Markets noted that two upcoming Tysabri-related events are not accounted for by the Street, giving rise to a "significant" undervaluing of the shares. Mylan (MYL) has submitted multiple unsolicited offers for Perrigo, and while the likelihood of the deal seems low given Perrigo's numerous rejections and Teva's (TEVA) 4.61% blocking stake in Mylan. BMO Capital remarked that a failed deal should see "limited downside" for Perrigo. There could certainly be near-term volatility if a Mylan agreement doesn't materialize, but the analyst was confident in the well-positioned company's ability to deliver on both earnings per share and cash flow. PRICE ACTION: Shares of Perrigo are up nearly 2% in afternoon trading. The company saw a nearly 25% leap following Mylan's initial offer on April 8, though it has since dipped from that high.
13:37 EDTDRIOn The Fly: Top stock stories at midday
Subscribe for More Information
10:00 EDTDTEGYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:14 EDTDRIOn The Fly: Pre-market Movers
Subscribe for More Information
09:02 EDTDRIDarden sees 20% of Olive Garden total sales will migrate to takeout over time
Subscribe for More Information
09:02 EDTDRIDarden expects 2016 traffic to be 'flattish', but will beat market
Subscribe for More Information
08:52 EDTDRIDarden expects two-thirds of 2016 EPS growth to be in 1H16
Subscribe for More Information
08:49 EDTTEVAMylan CFO to meet with Tel Aviv bourse head Wednesday, Reuters says
Subscribe for More Information
07:06 EDTDRIDarden sees FY16 adjusted EPS $3.05-$3.20, consensus $2.88
Sees FY16 same-restaurant sales growth of 2%-2.5%. Expects to open 18-22 restaurants in 2016. Sees FY16 total inflation of 1.5%-2%. Sees FY16 annual tax rate of 21%-24%. Sees FY16 total capital spending $230M-$255M.
07:05 EDTDRIDarden reports Q4 same-restaurant sales up 3.8%
Reports Q4 Olive Garden same-restaurant sales up 3.4%, Q4 LongHorn Steakhouse same-restaurant sales 5.2%; Q4 The Capital Grille same-restaurant sales up 4.4%; Q4 Eddie V's same-restaurant sales up 5.2%; Q4 Yard House same-restaurant sales up 3.2%; Q4 Seasons 52 same-restaurant sales up 3.1%; Q4 Bahama Breeze same-restaurant sales up 1.7%.
07:04 EDTDRIDarden reports Q4 adjusted EPS $1.08, consensus 93c
Subscribe for More Information
07:03 EDTDRIDarden to pursue separation of portion of company's real estate assets
Subscribe for More Information
05:29 EDTDTEGYDeutsche Telekom upgraded to Buy from Neutral at Nomura
Subscribe for More Information
June 22, 2015
15:04 EDTDTEGYT-Mobile could abandon DISH for Comcast, Forbes contributor says
Subscribe for More Information
15:00 EDTDRINotable companies reporting before tomorrow's open
Subscribe for More Information
11:12 EDTDRIDarden July volatility elevated into Q4 and outlook
Darden July call option implied volatility is at 25, July is at 24, October is at 25; compared to its 52-week range of 17 to 29, suggesting large near term price movement into the expected release of Q4 results on June 23.
09:06 EDTBIGBig Lots launches Big Lots Latino
Subscribe for More Information
06:54 EDTDRIDunkin' Brands and Darden are top picks heading into 2H 2015 at Credit Suisse
Subscribe for More Information
June 21, 2015
19:53 EDTTEVAMylan CEO says Teva's 4.61% stake may be 'illegal,' Bloomberg reports
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use